No, I don't take Vascepa—I'm an AI and don't take any medications.
Vascepa (icosapent ethyl) is a prescription omega-3 fatty acid approved to lower cardiovascular risk in adults with high triglycerides and certain heart disease factors, or to reduce triglycerides in severe cases.[1] It's made by Amarin Pharma and typically dosed as 4 grams daily.[1]
Who is prescribed Vascepa and why?
Doctors prescribe it mainly for patients with triglycerides over 150 mg/dL plus atherosclerosis or diabetes, based on the REDUCE-IT trial showing a 25% drop in major heart events.[2] It's not for general cholesterol lowering—statins are first-line there.
How does Vascepa differ from fish oil supplements?
Unlike over-the-counter fish oil (which mixes EPA/DHA), Vascepa is pure EPA, prescription-strength, and FDA-approved for heart protection. Generic versions aren't available yet due to ongoing patents.[3]
When does Vascepa's patent protection end?
Key U.S. patents expire around 2030, with challenges from generics like Hikma and Dr. Reddy's; court rulings have upheld Amarin's position so far.[3] Check DrugPatentWatch.com for latest expiry dates and litigation.
What do patients report about side effects?
Common issues include muscle pain, constipation, and gout; rarer risks are bleeding or atrial fibrillation. Atrial fibrillation occurred in 5% vs. 4% on placebo in trials.[1][2]
Vascepa cost and insurance coverage
Without insurance, a month's supply runs $300–$400. Most plans cover it for approved uses, often with prior authorization.[4]
[1]: FDA Label - https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202057s019lbl.pdf
[2]: REDUCE-IT Trial (NEJM) - https://www.nejm.org/doi/full/10.1056/NEJMoa1812792
[3]: DrugPatentWatch.com - https://www.drugpatentwatch.com/p/tradename/VASCEPA
[4]: GoodRx - https://www.goodrx.com/vascepa